Evaluation of the cardiopulmonary safety and effects of lorazepam as a premedicant.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous; D001285:Atropine / Q000008:administration & dosage; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects*; D055598:Chemical Phenomena; D002621:Chemistry; D002722:Chlorobenzenes / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000494:pharmacology*; D007273:Injections, Intramuscular; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D011229:Preanesthetic Medication; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013147:Spirometry
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D006993:Hypnotics and Sedatives; D001285:Atropine; D003975:Diazepam